Griffin Asset Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
FFAS
Griffin Asset Management's SBIO Position: Q2 2026 in Review
Griffin Asset Management reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 6.5% in Q2 2026, selling an estimated $110K and leaving 28,699 shares worth $1.86M. The position accounts for 0.2% of the portfolio, ranked #107.
Griffin Asset Management first reported a position in SBIO in Q4 2018 and has held it in 26 quarters since. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- Griffin Asset Management held 28,699 shares of ALPS Medical Breakthroughs ETF worth $1.86M as of Q2 2026.
- Griffin Asset Management sold 2,000 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $110K.
- ALPS Medical Breakthroughs ETF made up 0.2% of Griffin Asset Management's portfolio in Q2 2026, its #107 holding.
- Griffin Asset Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2018 and has held it in 26 quarters since.
- 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on Griffin Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.